Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Return on Equity: 2012

Historic Return on Equity for Sonoma Pharmaceuticals (SNOA) over the last 1 years, with Mar 2012 value amounting to -17.75%.

  • Sonoma Pharmaceuticals' Return on Equity rose 52889.00% to -3.48% in Q4 2012 from the same period last year, while for Dec 2012 it was -3.48%, marking a year-over-year increase of 52889.00%. This contributed to the annual value of -17.75% for FY2012, which is N/A change from last year.
  • As of FY2012, Sonoma Pharmaceuticals' Return on Equity stood at -17.75%.
  • Sonoma Pharmaceuticals' Return on Equity's 5-year high stood at -17.75% during FY2012, with a 5-year trough of -17.75% in FY2012.
  • For the 1-year period, Sonoma Pharmaceuticals' Return on Equity averaged around -17.75%, with its median value being -17.75% (2012).